These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11909733)

  • 1. Beta-carbolines as specific inhibitors of cyclin-dependent kinases.
    Song Y; Wang J; Teng SF; Kesuma D; Deng Y; Duan J; Wang JH; Qi RZ; Sim MM
    Bioorg Med Chem Lett; 2002 Apr; 12(7):1129-32. PubMed ID: 11909733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
    Meijer L; Borgne A; Mulner O; Chong JP; Blow JJ; Inagaki N; Inagaki M; Delcros JG; Moulinoux JP
    Eur J Biochem; 1997 Jan; 243(1-2):527-36. PubMed ID: 9030781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
    Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG
    Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
    Gong J; Ammanamanchi S; Ko TC; Brattain MG
    Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cell cycle inhibitor p21CIP is phosphorylated by cyclin A-CDK2 complexes.
    Jaumot M; Estañol JM; Casanovas O; Graña X; Agell N; Bachs O
    Biochem Biophys Res Commun; 1997 Dec; 241(2):434-8. PubMed ID: 9425288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity.
    Fotedar R; Fitzgerald P; Rousselle T; Cannella D; Dorée M; Messier H; Fotedar A
    Oncogene; 1996 May; 12(10):2155-64. PubMed ID: 8668341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle.
    Bresnahan WA; Boldogh I; Ma T; Albrecht T; Thompson EA
    Cell Growth Differ; 1996 Oct; 7(10):1283-90. PubMed ID: 8891332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insensitivity to growth inhibition by TGF-beta1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cells.
    Cipriano SC; Chen YQ
    Oncogene; 1998 Sep; 17(12):1549-56. PubMed ID: 9794232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stoichiometry of cyclin A-cyclin-dependent kinase 2 inhibition by p21Cip1/Waf1.
    Adkins JN; Lumb KJ
    Biochemistry; 2000 Nov; 39(45):13925-30. PubMed ID: 11076534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cip1 blocks the initiation of DNA replication in Xenopus extracts by inhibition of cyclin-dependent kinases.
    Strausfeld UP; Howell M; Rempel R; Maller JL; Hunt T; Blow JJ
    Curr Biol; 1994 Oct; 4(10):876-83. PubMed ID: 7850420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
    Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
    Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
    Orend G; Hunter T; Ruoslahti E
    Oncogene; 1998 May; 16(20):2575-83. PubMed ID: 9632134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trigger for centrosome replication found.
    Pennisi E
    Science; 1999 Feb; 283(5403):770-1. PubMed ID: 10049112
    [No Abstract]   [Full Text] [Related]  

  • 14. A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells.
    Coats S; Whyte P; Fero ML; Lacy S; Chung G; Randel E; Firpo E; Roberts JM
    Curr Biol; 1999 Feb; 9(4):163-73. PubMed ID: 10074425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity.
    Guadagno TM; Newport JW
    Cell; 1996 Jan; 84(1):73-82. PubMed ID: 8548828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines.
    Akama Y; Yasui W; Kuniyasu H; Yokozaki H; Akagi M; Tahara H; Ishikawa T; Tahara E
    Jpn J Cancer Res; 1996 Aug; 87(8):824-30. PubMed ID: 8797888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A vitamin D3 analog induces a G1-phase arrest in CaCo-2 cells by inhibiting cdk2 and cdk6: roles of cyclin E, p21Waf1, and p27Kip1.
    Scaglione-Sewell BA; Bissonnette M; Skarosi S; Abraham C; Brasitus TA
    Endocrinology; 2000 Nov; 141(11):3931-9. PubMed ID: 11089522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the concentrations of cyclins and cyclin-dependent kinases in extracts of cultured human cells.
    Arooz T; Yam CH; Siu WY; Lau A; Li KK; Poon RY
    Biochemistry; 2000 Aug; 39(31):9494-501. PubMed ID: 10924145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperoxia induces S-phase cell-cycle arrest and p21(Cip1/Waf1)-independent Cdk2 inhibition in human carcinoma T47D-H3 cells.
    Bilodeau JF; Faure R; Piedboeuf B; Mirault ME
    Exp Cell Res; 2000 May; 256(2):347-57. PubMed ID: 10772807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells.
    Carlson BA; Dubay MM; Sausville EA; Brizuela L; Worland PJ
    Cancer Res; 1996 Jul; 56(13):2973-8. PubMed ID: 8674031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.